To further support our findings on the actions of CgA to alter neuroblastoma phenotype and proliferation rates in vitro, we also used CRISPR-Cas9 to completely deplete CgA expression in the SH-SY5Y cells. This evidence concerns the gene CGA and neuroblastoma.